Bilateral Bronchoalveolar Lavage in Ventilator-associated Pneumonia
Pneumonia, Ventilator-Associated
About this trial
This is an interventional diagnostic trial for Pneumonia, Ventilator-Associated
Eligibility Criteria
Inclusion Criteria:
- invasive mechanical ventilation of ≥ 48 hours
- clinically suspected pneumonia (simplified Clinical Pulmonary Infectious Score exceeded 6 or chest radiographs with a new or progressive pulmonary infiltrate in a patient with at least two of the following: purulent respiratory secretions, temperature >38°C or <36°C, white blood cell count >12,000/mm3 or <4,000/mm3)
Exclusion Criteria:
- age <18 years
- pregnancy
- absence of informed consent
- an arterial oxygen partial pressure to inspired oxygen fraction ratio (PaO2:FiO2) of ≤150
- use of positive end-expiratory pressure (PEEP) >10 cmH2O
- active uncontrolled bronchospasm
- unstable angina or recent (<6 weeks) myocardial infarction
- unstable arrhythmia
- intracranial hypertension
- platelet count ≤20,000/mm3
- international normalized ratio (INR) or activated partial thromboplastin time (aPTT) ratio >1.5
- documented treatment-limitation orders in the patient's chart
Sites / Locations
Arms of the Study
Arm 1
Experimental
Bilateral BAL
Bronchoscopies are performed in strict accordance with consensus guidelines. The left or right lung is examined with a flexible fiberoptic bronchoscope. If localized infiltrates are present on the chest radiograph, the tip of the scope is wedged into a subsegment of the area displaying the most marked opacity. In the presence of diffuse opacity or when no clear roentgenographic abnormalities are observed, the tip is positioned in the lingula or right middle lobe. Five 20-ml aliquots of sterile normal saline are then injected and reaspirated with a syringe. Bronchoscopy is then repeated in the same manner in the contralateral lung with a second, sterile bronchoscope of the same brand and model.